Databases > biodbcore-000015

ready ChEMBL: a large-scale bioactivity database for drug discovery

Abbreviation:ChEMBL

Recommended
General Information
ChEMBL is an open large-scale bioactivity database containing information largely manually extracted from the medicinal chemistry literature. Information regarding the compounds tested (including their structures), the biological or physicochemical assays performed on these and the targets of these assays are recorded in a structured form, allowing users to address a broad range of drug discovery questions.


Collected/Recommended By



This record is maintained by johnpoverington  ORCID

Record updated: July 29, 2016, 2:21 p.m. by The FAIRsharing Team.





Access / Retrieve Data

Conditions of Use

Applies to: Data use

Data Versioning

Data Release

Data Curation

Data Access


REST Web Services



Connectivity



Credit

Record Maintainer

Funds

Maintains

Undefined

Grant Number(s)

  • 115002 (Innovative Medicines Initiative (IMI), Brussles, Belgium)

  • 602156 (European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom)

  • 654248 (The CORBEL Project)

  • 681002 (EU-ToxRisk)

  • CTTV008 (Centre for Therapeutic Target Validation, Cambridge, United Kingdom)

  • U54CA189205 (NIH Common Fund, USA)

  • WT086151/Z/08/Z (Wellcome Trust, UK)


Publications

ChEMBL: a large-scale bioactivity database for drug discovery.

Gaulton A., Bellis LJ., Bento AP., Chambers J., Davies M., Hersey A., Light Y., McGlinchey S., Michalovich D., Al-Lazikani B., Overington JP.,
Nucleic Acids Res. 2012

View Paper (PubMed)

The ChEMBL bioactivity database: an update

Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, Krüger FA, Light Y, Mak L, McGlinchey S, Nowotka M, Papadatos G, Santos R, Overington JP.
Nucleic Acids Res. 2013

View Paper (PubMed)